Search - tctmd.com

Displaying 61 - 80 of 126

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2021

Shelley Wood

May 31, 2021

News Daily News

Dapagliflozin US Cost-effectiveness Data Expose Barriers to HF Care

Shelley Wood

May 27, 2021

News Conference News ACC 2021

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

Michael O'Riordan

May 25, 2021

News Conference News ACC 2021

Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO

Michael O'Riordan

May 16, 2021

News Conference News ACC 2021

Sacubitril/Valsartan Lowers Triglycerides in HFpEF: PARAGON-HF

Yael L. Maxwell

May 16, 2021

News Conference News ACC 2021

PARADISE-MI: ARNI Doesn’t Surpass ACE Inhibitor After Acute MI

L.A. McKeown

May 15, 2021

News Daily News

Pneumonia in HF Patients Is Common, Lethal, and Preventable

L.A. McKeown

April 19, 2021

News Daily News

Hints of Benefit With Levosimendan in Pulmonary Hypertension Due to HFpEF

Michael O'Riordan

April 15, 2021

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2021

Shelley Wood

March 02, 2021

News Daily News

New FDA Indication Opens Up Use of Sacubitril/Valsartan in HFpEF

Todd Neale

February 16, 2021

News Daily News

ACC’s HFrEF Update Includes ARNI, SGLT2 Inhibitor Trials Plus Tips for Care

L.A. McKeown

January 11, 2021

News Opinion CV Team Dispatch

December 2020 News Roundup

L.A. McKeown

December 01, 2020

News Conference News AHA 2020

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

Michael O'Riordan

November 17, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2020

Shelley Wood

October 01, 2020

News Conference News ESC 2020

PARALLAX: Mixed Results for Sacubitril/Valsartan in HFpEF

Todd Neale

August 30, 2020

News Conference News ESC 2020

EMPEROR-Reduced: Empagliflozin Cuts Hospitalizations, CV Mortality in HFrEF

Michael O'Riordan

August 28, 2020

News Opinion CV Team Dispatch

August 2020 News Roundup

L.A. McKeown

August 01, 2020

News Daily News

Risk of Dying Doubled in Wuhan COVID-19 Patients With Hypertension

L.A. McKeown

June 08, 2020

News Daily News ACC 2020

Better QoL After MitraClip Plus Fewer Deaths, HF Hospitalizations: COAPT

Shelley Wood

March 17, 2020

News Features

Year in Review: DAPA-HF Tops Heart Failure News Amid Other Wins and Losses

Shelley Wood

December 23, 2019

Advertisement

TCTMD’s Top 10 Most Popular Stories for May 2021

Dapagliflozin US Cost-effectiveness Data Expose Barriers to HF Care

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO

Sacubitril/Valsartan Lowers Triglycerides in HFpEF: PARAGON-HF

PARADISE-MI: ARNI Doesn’t Surpass ACE Inhibitor After Acute MI

Pneumonia in HF Patients Is Common, Lethal, and Preventable

Hints of Benefit With Levosimendan in Pulmonary Hypertension Due to HFpEF

TCTMD’s Top 10 Most Popular Stories for February 2021

New FDA Indication Opens Up Use of Sacubitril/Valsartan in HFpEF

ACC’s HFrEF Update Includes ARNI, SGLT2 Inhibitor Trials Plus Tips for Care

December 2020 News Roundup

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

TCTMD’s Top 10 Most Popular Stories for September 2020

PARALLAX: Mixed Results for Sacubitril/Valsartan in HFpEF

EMPEROR-Reduced: Empagliflozin Cuts Hospitalizations, CV Mortality in HFrEF

August 2020 News Roundup

Risk of Dying Doubled in Wuhan COVID-19 Patients With Hypertension

Better QoL After MitraClip Plus Fewer Deaths, HF Hospitalizations: COAPT

Year in Review: DAPA-HF Tops Heart Failure News Amid Other Wins and Losses

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content